GPAM and Obesity: Small molecule inhibitors of GPAT, several compounds with series of benzoic and phosphonic acids, were designed and synthesized as potential pharmacological strategies for obesity and metabolic diseases linked with increased TAG synthesis by Wydysh and his colleagues56, 57.